glp 1 drugs and gallbladder Peptide/GLP-1 Complications: 11 Hidden Risks Side Effects You Must Know GLP-1 receptor agonists and gallbladder
Description
Many patients with cardiometabolic syndrome develop metabolic dysfunction-associated steatohepatitis (fatty liver disease)
Critically, Ozempic carries a Boxed Warning regarding the potential risk of thyroid C-cell tumors, including medullary thyroid carcinoma, based on rodent studies
J Diabetes Invest 2018
Microdosing is considered off-label use, or prescribing an approved drug for an unapproved use, which doctors are allowed to do if they deem it medically appropriate
These effects do not significantly differ between various GLP-1R agonists
